CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Buprenorphine transdermal patch

Last Updated: October 15, 2010
Result type: Reports
Project Number: SR0211-000
Product Line: Reimbursement Review

Generic Name: Buprenorphine transdermal patch

Brand Name: BuTrans

Manufacturer: Purdue Pharma

Therapeutic Area: Pain, persistent (moderate intensity)

Indications: Pain, persistent (moderate intensity)

Submission Type: Initial

Project Status: Cancelled